Company profile
Inspire Medical Systems, Inc.
NYSE: INSP · Healthcare · Medical - Devices
#161 of 1,422 Healthcare companies by revenue60th-percentile growth
EA Score
78B+FH 89DQ 70GM 66SS 71
v0.1 · 65/100 weight · provisional
↑ return on assets, net margin · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$915.2M
Rev growth YoY (TTM)
+8.9%
Net income (FY)
$145.4M
Employees
1,333
as of 2026-08-10
Market cap
$1.7B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$912.0M$912.0M2025
Net income$145.4M$145.4M2025
Operating income$51.0M$51.0M2025
Total assets$907.3M$907.3M2025
Liabilities$126.2M$126.2M2025
Equity$781.2M$781.2M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Operating100%
By geography
UNITED STATES96%
Non-US4%
The read
What is Inspire Medical Systems, Inc.’s revenue?
Inspire Medical Systems, Inc. booked $912.0M in FY2025 revenue, growing 14% year over year — faster than most Healthcare companies we track, at a 15.9% net margin.
Peers · Healthcare
Madrigal Pharmaceuticals, Inc.64CThe Pennant Group, Inc.73BIonis Pharmaceuticals, Inc.71BNeogen Corporation65BANI Pharmaceuticals, Inc.82B+Nutex Health, Inc.68BNeighbors
Hennepin →Key facts
CEOTimothy Herbert
SectorHealthcare
IndustryMedical - Devices
HeadquartersGolden Valley, MN
ExchangeNYSE: INSP
Employees1,333
IPO date2018-05-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.